MedPath

I.M. Sechenov First Moscow State Medical University

I.M. Sechenov First Moscow State Medical University logo
🇷🇺Russia
Ownership
Private
Established
1758-01-01
Employees
5K
Market Cap
-
Website
http://www.mma.ru

Use of Erbium Laser for Extraction of the Third Molars

Not Applicable
Not yet recruiting
Conditions
Third Molar Extraction
Impacted Third Molar Tooth
Interventions
Procedure: Third molar extraction by cutting and rotary tools
Procedure: Third molar extraction by erbium laser with wavelength 2.94 nm
First Posted Date
2022-09-14
Last Posted Date
2022-09-14
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
60
Registration Number
NCT05540015

Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts.

Recruiting
Conditions
Cardiotoxicity
First Posted Date
2022-08-19
Last Posted Date
2023-09-28
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
150
Registration Number
NCT05508087
Locations
🇷🇺

Sechenov University, Moscow, Russian Federation

Оptical Spectroscopy in the Diagnosis of Intra-articular Injuries

Completed
Conditions
Cartilage Destruction
First Posted Date
2022-07-12
Last Posted Date
2024-01-18
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
48
Registration Number
NCT05454605
Locations
🇷🇺

Russia, Moscow, Russian Federation

Intestinal Permeability and Intestinal Microbiota in Irritable Bowel Syndrome

Phase 4
Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
Drug: prescribing anapproved drug, examination
First Posted Date
2022-05-18
Last Posted Date
2022-05-18
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
60
Registration Number
NCT05379036
Locations
🇷🇺

Elena Poluektova, Moscow, Russian Federation

Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.

Not Applicable
Recruiting
Conditions
Arrhythmia
Conduct Disorder
Hypertension
Endothelial Dysfunction
Chronic Heart Failure
Chronic Coronary Syndrome
Diastolic Dysfunction
Exercise Tolerance
COVID-19
Oxygen Consumption
Interventions
Procedure: Intermittent hypoxic-hyperoxic training
Procedure: Intermittent hypoxic-hyperoxic training/control
First Posted Date
2022-05-18
Last Posted Date
2023-11-22
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
60
Registration Number
NCT05379608
Locations
🇷🇺

University Clinical Hospital No. 4 of I.M. Sechenov First Moscow State Medical University (Institute for personalized cardiology, Center "Digital biodesign and personalized healthcare")., Moscow, Russian Federation

Clinical and Neurophysiological Characteristics of Narcolepsy

Completed
Conditions
Narcolepsy Type 1
First Posted Date
2022-05-17
Last Posted Date
2024-03-13
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
89
Registration Number
NCT05375890
Locations
🇷🇺

Regional Clinical Hospital No.3, Chelyabinsk, Russian Federation

🇷🇺

FSBI NMRCO FMBA Russia, Moscow, Russian Federation

🇷🇺

Almazov National Medical Research Centre, Saint Petersburg, Russian Federation

and more 8 locations

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Not Applicable
Completed
Conditions
Anticoagulants
Interventions
Other: prescribing anticoagulant therapy
First Posted Date
2022-04-08
Last Posted Date
2022-04-08
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
1000
Registration Number
NCT05319340

Micophenolate Mofetil Versus Azathioprine in Myocarditis

Phase 3
Conditions
Lymphocytic Myocarditis (Disorder)
Dilated Cardiomyopathy
Heart Failure
Cardiomyopathies
Sudden Cardiac Death
Interventions
First Posted Date
2022-02-14
Last Posted Date
2022-02-14
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
50
Registration Number
NCT05237323
Locations
🇷🇺

I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Bol'shaya Pirogovskaya Street 6, 1 Building ,, Russian Federation

Probiotics and Hemodynamic Changes in Cirrhosis

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
Drug: Saccharomyces Boulardii Probiotic Supplement
Drug: Placebo
First Posted Date
2022-02-09
Last Posted Date
2022-03-31
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
40
Registration Number
NCT05231772
Locations
🇷🇺

Clinic for Internal Diseases, Gastroenterology and Hepatology at Sechenov University, Moscow, Russian Federation

Cardiovascular Risk Predictors in Patients With Psoriasis

Completed
Conditions
Psoriasis
Cardiovascular Diseases
First Posted Date
2022-01-21
Last Posted Date
2024-10-07
Lead Sponsor
I.M. Sechenov First Moscow State Medical University
Target Recruit Count
200
Registration Number
NCT05200598
Locations
🇷🇺

University Clinical Hospital #2, Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath